CLEVELAND — We are learning more about President Trump's treatment. His doctors are using an experimental treatment that includes two anti-bodies to treat the infection. One of those antibodies is dexamethasone.
Infectious disease specialist, Dr. Amy Edwards with University Hospitals, explains the treatment.
“What Regeneron is doing is they're making a product that has two monoclonal antibodies, it's a mix of two monoclonal antibodies each to a different site of the SARS-CoV-2 virus in the hopes that if the host isn't making enough antibody to fight the virus off, then this monoclonal antibody will help.”
But we know this is an experimental drug only used on patients with severe symptoms. So we asked Dr. Edwards if this because the president’s case is severe? Or are they taking every extra precaution because he is the most high-profile patient in the world at the moment?
“My guess is it's because it's the president. When the president's physician spoke yesterday … I listened to his statement yesterday and he was very clear that at least at this time President Trump was not on any oxygen. For me that's a really good sign and I would definitely put him in the more mild category for that reason.”
Dr. Edwards also explains that this treatment has definite risks that his doctors will be monitoring. And if President Trump ends up back at the White House by Monday afternoon, Dr. Edwards says he’s not exactly out of the woods yet. But going home is a good sign.